Si usted conoce a alguien con el cancer, y ellos van a recibir tratamientos de radiacion y quimioterapia; este libro puede ayudar a aliviar el dolor y la incomodidad causada por estos tratamientos asperos las tecnicas y los productos secretos descritos en estas paginas seran el differance entre su comodidad y su miseria Este libro hace un gran regalo

What is it really like to hear the words "you have throat cancer"? In Bangers and Mash, food-and wine-loving photographer Keith Hern tells us with honesty and humour exactly what it's like. From the grim reality of chemotherapy and radiotherapy treatments to unexpected moments of real warmth and kindness from friends old and new, the fight to survive is vividly described. With the help of an NLP coach, Keith challenges the cancer head-on and emerges triumphant into a new, more colourful world. A powerfully uplifting read.

A comprehensive resource on case studies of marketed kinase drugs and promising drug trials

Since the discovery of protein kinase activity in 1954, the field of protein kinase drug discovery has advanced dramatically. With the ongoing clinical success of the Bcr-Abl kinase inhibitor Gleevec in the treatment of chronic myelogenous leukemia and seven additional marketed kinase inhibitor drugs, researchers have compelling evidence that kinase inhibitors can be highly efficacious in the treatment of diseases caused by aberrant activity of protein kinase. Currently more than 100 protein kinase inhibitors are in clinical development.

In one comprehensive volume, the editors, Dr. Rongshi Li and Dr. Jeffrey Stafford, present timely and important case studies of marketed kinase drugs and several of the most advanced kinase inhibitors in clinical trials. "Kinase Inhibitor Drugs" includes:

Case studies from leading investigators and experts in the field that provide firsthand accounts of kinase inhibitor discovery

Current thinking on kinase structure, biochemistry, and signal transduction pathways

Information on state-of-the-art technologies and tools such as structure-based and fragment-based drug discovery

A lineup of clinical-phase growth factor receptor inhibitors

Inhibitors of cell cycle kinases

The discovery of allosteric inhibitors of MEK kinase

Information on pharmacogenomics and its application to kinase inhibitor clinical development

The first and second editions of this best-selling guide have already helped thousands of people understand chemotherapy and prepare themselves or their loved ones for treatment. The book is used as the primary chemotherapy patient education tool in outpatient clinics nationwide. This new third edition of The Chemotherapy Survival Guide includes updated information on topics including biotherapy, immunotherapy, nutrition, stress reduction, chemotherapy drugs, and more. Written by experienced oncology nurses Judith McKay and Tamera Schacher, this reassuring, optimistic guide helps readers understand their treatment options and explains in plain English how different types of chemotherapy really work. The book includes detailed advice on how to cope with and alleviate the side effects of chemotherapy, such as hair loss and nausea, and describes how good nutrition, meditation, support groups, and other techniques and resources can help chemotherapy patients recover both physically and emotionally during this difficult time.

Calcium D-glucarate, now available as a supplement, has been shown to be effective in reducing the risk of various cancers by eliminating toxins from the body. State-of-the-art research confirms the potential of this nutrient as a major tool in cancer risk reduction.

This volume examines an important aspect of the search for effective anti-tumour agents -- the superoxide dismutase models. The authors consider the complex compounds of transition metals which imitate the catalytic properties of superoxide dismutases from the point of view of their pharmacological applicability.

In 1985 the media announced a new therapy for cancer. It was expensive, labor-intensive, and toxic--but, they said, it worked. How it worked is the story Ilana Lowy tells in "Between Bench and Bedside," a compelling account of the clinical trials of interleukin-2 at a major French cancer hospital. Her book offers a remarkable insider's view of the culture of clinical experimentation in oncology--and of how this culture affects the development of new treatments for cancer.

Lowy, a historian of science who trained as an immunologist, makes the life of the laboratory and the hospital comprehensible and immediate. Before immersing us in the clinical drama, she fills in the history behind the action--a background of chemotherapy and radiation, controlled clinical trials, and the long line of immunological approaches that finally led to interleukin-2. The story then shifts to the introduction of interleukin-2 in a cancer ward. Lowy conveys the clinical investigation as a complex, multilayered phenomenon that defies the stereotypes of modern biomedicine. In this picture, the miracle-makers and arrogant, self-centered professionals of myth give way to moving images of real people negotiating the tensions between institutional and professional constraints, the search for a scientific breakthrough, and the obligation to alleviate the suffering of a patient. The result is a rare firsthand look at the multiple factors that shape real-life clinical experiments and the institutional tangle and emotional muddle that surround such trials--an invaluable view at a time when medicine is undergoing such great and confusing changes.

In the last decade the use of interstitial microwave antennas to deliver localized and controlled power to deep-seated tumours has been explored in institutes around the world. Simultaneously the field of brachytherapy also progressed as clinicans began to develop new implantation approaches for a variety of tumour sites, thereby promoting the insertion of catheters which could serve as conduits for the insterstitial microwave applicators. Although the challenges presented by deep-seated tumours have not been solved, the developments in the field of brachytherapy and the implantation of interstitial applicators for hyperthermia are such that a volume dedicated to this approach is warranted. This third volume in the series "Hyperthermia and Oncology" provides insight in and updated information on various aspects of interstitial hyperthermia. It aims to serve as a guide for clinicians who are either already working in the field or who wish to implement this treatment. It also provides basic aspects to physicists and biologists who are interested in the field of hyperthermic treatment.

First Published in 1988. This is a collection of the Proceedings of a course held at the International School of Medical Sciences Ettore Majorana Centre for Scientific Culture, Italy 5-13 September 1986.